Clinical Trial Update: Predictors of Proton Pump Inhibitor (PPI) Response in Eosinophilic Esophagitis [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/Phase 2 clinical trial evaluating predictors of proton pump inhibitor response in eosinophilic esophagitis and gastroesophageal reflux disease has bee…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Eosinophilic Esophagitis
• Gastroesophageal Reflux Disease

Drugs mentioned

• Proton Pump Inhibitors

Snippet

Sponsor: Mayo Clinic | Conditions: Gastroesophageal Reflux Disease, Eosinophilic Esophagitis | Phase 1, Phase 2 | Status: WITHDRAWN